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Summary
Background: Maternal obesity is associated with offspring cardiometabolic risk.
UPBEAT was a randomised controlled trial of an antenatal diet and physical activity
intervention in 1555 women with obesity. The intervention was associated with
lower gestational weight gain, healthier diet and metabolic profile in pregnancy, and
reduced infant adiposity at six months.
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Objective:We have investigated whether the UPBEAT intervention influenced child-
hood cardiometabolic outcomes or was associated with sustained improvements in
maternal lifestyle 3-years after delivery.
Methods: In UPBEAT mother-child dyads at the 3-year follow-up, we assessed child-
hood blood pressure, resting pulse rate, and adiposity (body mass index, skinfold
thicknesses, body fat, waist and arm circumferences) and maternal diet, physical
activity, and anthropometry.
Results: 514 three-year-old children attended the appointment (49% intervention,
51% standard care). There was no difference in the main outcome of interest, sub-
scapular skinfold thickness, between the trial arms (−0.30 mm, 95% confidence inter-
val: −0.92, 0.31). However, the intervention was associated with a lower resting
pulse rate (−5 bpm [−8.41, −1.07]). There was also a non-significant lower odds of
overweight/obesity (OR 0.73; 0.50, 1.08). Maternal dietary improvements observed
in the UPBEAT trial, including glycaemic load and saturated fat were maintained
3-years postpartum.
Conclusion: This study has demonstrated that an antenatal dietary and physical activ-
ity intervention in women with obesity is associated with lower offspring pulse rate
and sustained improvement in maternal diet. Whilst larger than previous cohorts,
there remains potential for bias from attrition and these findings require validation in
future cohorts.
K E YWORD S
cardiovascular function, childhood obesity, developmental origins, maternal obesity, randomised
controlled trial
1 | INTRODUCTION
The World Health Organization (WHO) estimates that the global preva-
lence of childhood overweight and obesity will reach 70 million by
2025.1 The causal pathways, widely explored in observational studies2,3
suggest that maternal obesity may contribute to the development of
childhood obesity through exposures during in utero development,4,5
which remain following adjustment for confounders.6,7 These relation-
ships have been observed in animal studies, in which environmental and
genetic contributions can be tightly controlled.8 In contrast, observa-
tional studies using Mendelian randomisation, in which maternal genetic
variants are used as instrumental variables to test the effect of maternal
obesity on offspring adiposity, have not supported a causal intrauterine
effect of greater maternal BMI on offspring adiposity,9,10 inferring that
the relationship is explained by shared genetic traits.
Epidemiological observations from mother-child cohorts have also
reported associations between maternal obesity and cardiovascular
morbidity and mortality rates in their children.11,12 The inference of in
utero effects of maternal obesity on offspring cardiovascular function
is supported by animal models; numerous studies in experimental ani-
mals, reported by ourselves13,14 and others,15 have described a rela-
tionship between pre-pregnancy maternal obesity and offspring
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cardiovascular dysfunction, including heart rate variability, enhanced
cardiovascular response to stress, hypertension and higher circulating
atherogenic lipids,16-18 observations which have been reported con-
sistently across species.
Many antenatal randomised controlled trials (RCTs) have
attempted to reduce gestational weight gain (GWG) or improve obe-
sity related pregnancy outcomes, especially gestational diabetes
through antenatal diet and/or physical activity interventions.19,20
Whilst improvement in gestational diabetes and other antenatal clin-
ical outcomes has seldom been achieved, the majority of interven-
tions have shown some benefit in limiting GWG and improving self-
reported diet.20 These RCTs provide an important opportunity to
explore the causal relationship between maternal obesity and subse-
quent obesity and cardiovascular risk in the offspring, by studying
children born to women who participated in these trials. However,
few studies have progressed to childhood follow-up and, in those,
that have, the sample size has frequently been inadequate to detect
any effects with certainty.21
The UK Pregnancies Better Eating and Activity Trial (UPBEAT),
was a multi-centre RCT of a dietary and physical activity intervention
in 1555 pregnant women with obesity.22 Women were randomised to
an intensive 8-week behavioural intervention or to standard antenatal
care. The intervention had no effect on the primary outcomes, the
incidence of gestational diabetes and large for gestational age (LGA)
infants. However, there were improvements in several secondary
maternal outcomes; specifically, lower total GWG, sum of skinfold
thicknesses, dietary glycaemic load (GL) and saturated fat intake
(SFA), and a modest increase in self-reported physical activity. The
intervention also contributed to a healthier metabolic profile across
pregnancy.23 At six months postpartum we found the maternal dietary
benefits of the intervention were sustained and also observed a lower
infant subscapular skinfold thicknesses in the offspring of women
randomised to the intervention.24 The aim of the present study was
to assess whether the UPBEAT intervention influenced childhood adi-
posity and cardiovascular function at three years of age and if
improvements in maternal lifestyle behaviours were sustained three
years after delivery.
2 | PATIENTS AND METHODS
2.1 | Study design and setting
This was a secondary analysis of the UPBEAT RCT.22 We undertook a
three-year postpartum follow-up study in eight trial centres. In the
original trial, 1 555 women with obesity (≥16 years of age; pre-
pregnancy BMI≥30 kg/m2) were recruited in early pregnancy; exclu-
sion criteria included pre-existing disease and multiple pregnancy. The
participants were randomised to the intervention or standard antena-
tal care at 15+0-18+6 weeks' gestation as reported previously.25 In
brief, the intention of the intervention was to prevent GDM through
the promotion of healthy dietary intake and incremental increases in
daily physical activity, over the 8-week intervention period. The
dietary recommendations focused on reducing GL and SFA intake and
were tailored to the woman's habitual diet and cultural preferences.
With respect to daily exercise, all women were provided with a
pedometer and a DVD of suitable exercises. Further details are avail-
able in the protocol.25
2.2 | Participants and consent
All participants provided written informed consent. Consent to the
trial included agreement to contact the participants at a later date
(UK Integrated Research Application System, IRAS, ref 09/H0802/5).
The follow-up study design and protocol were approved by the NHS
Research Ethics Committee (UK Integrated Research Application Sys-
tem ref 13/LO/1108). Between August 2014 and October 2017, all
participants in the trial were invited to attend a three year post-
delivery visit with their child.22 Research midwives/research assistants
completed the data collection. Continued training and regular contact
between the sites was sustained throughout the data collection
period. Women were excluded from the analysis if they were preg-
nant or had given birth in the previous four months at the time of
follow-up. Children were excluded if they were suffering from severe
illness (n = 4) (chronic lung disease, developmental delay, down's syn-
drome and Spina bifida) as these could affect growth or development
or if they were born before 34 weeks' gestation (n = 5).
2.3 | Childhood outcomes
Since we had previously reported lower subscapular skinfold thickness
in six month old children in the intervention, compared with the con-
trol arm,24 subscapular skinfold thickness was the pre-specified child-
hood outcome of interest for the present study. Additional offspring
outcomes included triceps, bicep, suprailiac, and abdomen skinfold
thicknesses, and sum of skinfold thicknesses (calculated by addition of
the five measures). All skinfold thicknesses were evaluated in triplicate
using Holtain children skinfold callipers. Mid-upper arm and waist cir-
cumferences, estimated total body fat percentage (by bioelectrical
impedance analysis; BIA, ImpediMed SFB7), weight (using a calibrated
scale), WHO growth standard BMI z-score,26 and age adjusted Inter-
national Obesity Task Force (IOTF) BMI centiles were also deter-
mined.27 The WHO reference standards are adjusted for age and sex
and applicable irrespective of ethnicity and mode of early infant feed-
ing. Childhood overweight and obesity were defined by IOTF sex-
specific centiles (90.5th and 98.8th centiles for boys and 89.3th and
98.6th centiles for girls).27
For BIA estimation of body fat percentage, the child was asked to
lie on a couch for five minutes during data collection, after which
blood pressure was measured in duplicate when feasible and a single
resting pulse rate measurement was recorded by a WelchAllyn
53S00-E4 device, with an appropriately sized arm cuff. This order
ensured measurement of resting pulse rate. Blood pressure was
converted to age and height appropriate centiles.28
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2.4 | Maternal outcomes
Maternal diet and physical activity were assessed with the same ques-
tionnaires used in the original UPBEAT study 25. These included a
semi-quantitative food frequency questionnaire to estimate dietary
GL, macronutrient, and energy intake. Women were excluded from
this analysis if calorie intake was calculated to be under-reported at
the baseline visit (15+0-18+6 weeks' gestation). Physical activity was
assessed using the International Physical Activity Questionnaire
(IPAQ) and summarised as metabolic equivalents (METs) of energy
expenditure.29 Maternal anthropometric measurements at the three
year follow-up included mid-upper arm, waist and thigh circumfer-
ences, subscapular, triceps, bicep, and suprailiac skinfold thicknesses
(measured in triplicate using skinfold callipers). BMI was calculated
from weight and height data using standardised methods.
2.5 | Statistical analyses
For summary statistics, binary and categorical variables are presented
using counts and percentages. The distribution of continuous vari-
ables was assessed using coefficients of skewness and then
summarised by mean and SD or median and interquartile range, where
appropriate. Comparison of demographic details were made between
the intervention and control groups; if the outcome of interest was
binary, an odds ratio was calculated, when categorical, chi-squared
test was used. Mann-Whitney U tests or t tests were used for contin-
uous data, depending on the distribution of the data.
2.5.1 | Effect of the intervention on maternal and
offspring outcomes three years postpartum
To analyse the effect of the intervention a complete case analysis
(including only those with complete data on all variables used in any
analyses) was undertaken for all participating mothers and children.
Treatment effects for continuous outcomes were expressed as differ-
ences in means obtained from multivariable linear or quantile regres-
sion. Linear regression was used for most outcomes, with quantile
regression employed for sum of skinfolds and maternal physical activ-
ity as the data were positively skewed. Binary endpoints were
expressed as odds ratios with 95% confidence interval using logistic
regression. Analyses were adjusted for minimisation variables (mater-
nal BMI at trial enrolment, parity and ethnicity) and child sex and age
at follow-up.
2.5.2 | Sensitivity analyses to explore selection
bias due to attrition
Although attrition was similar in each trial arm, we explored potential
selection bias due to loss to follow-up by comparing maternal baseline
characteristics and neonatal outcomes by randomisation arm for those
included in this analysis (n = 514) with those lost to follow-up
(n = 1 006).
We undertook additional analyses, imputing missing childhood
outcome data due to loss to follow-up. For the offspring outcomes
we used multivariate imputation chained equations to impute missing
data for childhood adiposity and cardiovascular outcomes, to provide
a total sample size of n = 1 520. Data were imputed to create
50 datasets using 10 burn-in iterations for live-born infants using the
multivariate imputation model including: maternal early pregnancy
BMI, age, ethnicity, parity, early pregnancy smoking status,
randomisation arm, measures of maternal anthropometry including
GWG, maternal diet (glycaemic load, saturated fat, carbohydrate, pro-
tein, energy intake) and physical activity at 27+0-28+6, 34+0-36+0
weeks' gestation, gestation at delivery, birthweight, mode of feeding
on hospital discharge and 3-year maternal diet (glycaemic load, satu-
rated fat, carbohydrate, protein, energy intake) and physical activity,
and child sex and age at follow up. Analyses were performed using
Stata version 15.0 (StataCorp, College Station, TX, USA).
3 | RESULTS
3.1 | Participants
One thousand, five hundred and fifty-five participants were
randomised to the UPBEAT trial and 1233 were approached between
three to four years after delivery with 1018 of these responding to
contact. The predominant reason for the reduction in numbers con-
tacted compared to the original study population was the child being
outside the prescribed age range. Of the women originally
randomised, n = 514 (33%) mother-child dyads took part (n = 250
intervention; 264 standard antenatal care), Figure 1. For the
514 mothers and children, 495 had complete outcome data, with
10 providing only questionnaire data completed at home. Nine chil-
dren were excluded on the basis of severe illness or delivery
<34 weeks' gestation. For those who completed the follow-up there
was no difference in the majority of maternal baseline (trial entry)
characteristics (Table 1) or neonatal characteristics (Table 2) between
the intervention and standard care arm, except for a significantly
higher odds ratio of LGA and a higher birthweight for infants in the
intervention arm. Mothers who attended the three-year follow-up
were on average, compared to those who did not attend, older
(1.1 years), had a lower early pregnancy BMI, more likely to be White
European and nulliparous, and less likely to smoke (Supplementary,
Table S1). There was a higher proportion of breastfeeding on hospital
discharge amongst infants who completed the three-year follow-up
(Supplementary, Table S2).
In this sub-population (n = 514), and in common with the original
trial, sum of maternal skinfold thicknesses at 26+0-28+6 weeks' gesta-
tion were lower in the intervention arm compared to the standard care
arm, as were GL and reported SFA intake (Supplementary, Table S3).
In common with the main trial population, physical activity was higher
in those in the intervention arm (Supplementary, Table S3). In contrast
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to the main trial, there was no significant difference in total GWG
between the intervention and control groups (difference in mean in
main trial −0.55 kg (95% CI: −1.08 to −0.02) vs −0.38 kg (−1.17 to
0.42), or in the metabolic profile in pregnancy (Supplementary,
Figure S1).22,23
3.2 | Intervention effects on childhood adiposity
outcomes
34% of all children with adiposity measurements were classified as
having a BMI equivalent to the adult BMI classification of
≥25.0 kg/m2, with 8% having obesity. The mean (SD) BMI z-score was
0.88 (1.0). There were no differences in the adjusted coefficients for
BMI z-score between the intervention and standard care arms.
Despite a trend for lower odds of overweight/obesity in the interven-
tion arm (OR 0.73; 95CI: 0.50, 1.08) and for lower adiposity as
measured by skinfold thicknesses there was no statistical evidence for
a difference between arms (Table 3): for the primary outcome of sub-
scapular skinfold thickness the adjusted difference in mean was
−0.30 mm (95% CI: −0.92 to 0.31), for sum of skinfold thicknesses.
−2.00 mm (95% CI −4.64 to 0.62) and for body fat percentage
(by bioelectrical impedance analysis) −0.30% (95% CI −1.62 to 1.01).
There were also no differences in the adjusted coefficients for waist
circumference and mid-upper arm circumference between trial arms
(Tables 3).
3.3 | Intervention effects on child cardiovascular
outcomes
Resting pulse rate was −5 beats per minute (bpm) (−8.6 to −1.07)
lower in the intervention arm (P < 0.01), compared with standard care
(Table 3). Further analysis identified a bimodal distribution of pulse
F IGURE 1 Consort diagram
of participants enrolled in the
UPBEAT trial at 3 years after
delivery
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rate in children in both trial arms (Figure 2). Bimodality was not associ-
ated with maternal dietary intake and resting pulse rate in pregnancy,
child dietary intake, child's BMI z-score, physical activity, sedentary
time and time of day, season or trial centre. Logistic regression identi-
fied a shift from the higher (76-135 bpm) to the lower (45-75 bpm)
modality as a result of the intervention; odds ratio 0.54 (0.32, 0.90). A
TABLE 1 UPBEAT 3-year follow-up: Comparison of maternal characteristics of those who attended the 3-year follow-up, by
randomisation arm
Maternal
Mean (SD)/ Median (IQR) N (%)
Difference in means/ OR
(95%CI)Intervention Control
Age (years) at baseline 250 31.2 (5.0) 264 31.3 (5.5) −0.09 (−1.01 to 0.82)
BMI (kg/m2) at baseline 250 34.5
(32.5-38.0)
264 34.9
(32.6-37.8)
−0.14 (−0.96 to 0.68)
ethnicity Asian 250 13 (5) 264 9 (3) 1.47 (0.61 to 3.52)
Black 55 (22) 64 (24) 0.87 (0.57 to 1.32)
White 173 (69) 176 (67) ref
Other 9 (4) 15 (6) 0.61 (0.26 to 1.43)
Multiparous 250 124 (50) 264 138 (52) 0.90 (0.63 to 1.27)
Smoking status at baseline 250 5 (2) 264 14 (5) 0.88 (0.56 to 1.38)
IMD quintilesa 1 (least deprived) 247 14 (6) 264 16 (6) 0.78 (0.36 to 1.68)
2 21 (8) 15 (6) 1.24 (0.61 to 2.55)
3 28 (11) 30 (11) 0.83 (0.46 to 1.50)
4 75 (31) 106 (40) 0.63 (0.42 to 0.94)
5 (mot deprived) 109 (44) 97 (37) ref
Sum of skinfolds (cm) at baseline 246 121.6 (29.5) 263 122.7 (25.7) −1.15 (−5.97 to 3.66)
Antenatal
characteristics
GDMb 234 56 (24) 250 69 (27) 0.82 (0.55 to 1.24)
PEc 249 6 (2) 260 10 (4) 0.62 (0.22 to 1.72)
Total GWG from
15-18 weeksd
222 7.3 (4.5) 230 7.7 (4.2) −0.38 (−1.17 to 0.42)
Abbreviations: BMI, body mass index; CI, confidence intervals; GDM, gestational diabetes; GWG, gestational weight gain; IMD, indices of multiple depriva-
tion; IQR, interquartile range; PE, pre-eclampsia; SD, standard deviation.
aIMD quintiles are calculated for the region of residence, by fifths of the population. UK wide scores were developed by reconciling Scottish data to English
norms.
bGestational diabetes (GDM) diagnosis by International Association of Diabetes in Pregnancy Study Group criteria at 27 + 0 to 28 + 6 weeks' gestation.
cPre-eclampsia defined as systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mm Hg, or both, on at least two occasions 4 hours apart, with
proteinuria ≥ 300 mg/ 24 hours.
dTotal gestational weight gain calculated using estimated weight before pregnancy and weight at 36 weeks’.
TABLE 2 UPBEAT 3-year follow-up: Comparison of neonatal characteristics, of those who attended the 3-year follow-up, by
randomisation arm
Mean (SD)/ N (%)
Difference in means/
OR (95% CI)Intervention Control
Birth characteristics Gestation at birth (weeks) 250 39.8 (1.5) 264 39.5 (2.2) 0.25 (−0.07 to 0.58)
Anthropometry Birthweight (grams) 250 3523 (526) 264 3426 (578) 97.2 (1.3 to 193.0)
Birthweight >4 kg 250 40 (16) 264 28 (11) 1.6 (0.95 to 2.69)
LGA >90th Centilea 250 39 (15) 264 25 (9) 1.76 (1.03 to 3.01)
Subscapular skinfold thickness (mm) 113 5.7 (1.4) 113 5.5 (1.3) 0.24 (−0.13 to 0.61)
Triceps skinfold thickness (mm) 115 5.3 (1.3) 119 5.2 (1.6) 0.08 (−0.30 to 0.47)
Neonatal feeding history at 72 hours Formula feeding 249 47 (19) 264 53 (20) 0.91 (0.58 to 1.43)
Breast feeding 158 (63) 163 (62) Ref
Partially breastfeeding 44 (18) 48 (18) 0.94 (0.59 to 1.50)
Abbreviations: CI, confidence intervals; LGA, large for gestational age; OR, odds ratio; SD, standard deviation.
aCustomised birthweight centile adjusting for maternal height and weight, ethnicity, parity and sex of the infant.
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TABLE 3 UPBEAT 3-year follow-up: Child anthropometry at 3 years of age, by UPBEAT randomisation arm
Mean (SD)/ Median (IQR) N (%)
Difference in means /Odds ratio
(95% CI)a P-valueIntervention Control
Child age at 3-year follow up (months) 250 41.8 (3.4) 264 41.8 (3.4) 0.05 (−0.53 to 0.64) .85
Weight (kg) 240 17.2 (2.7) 254 17.1 (2.9) 0.16 (−0.30 to 0.63) .49
height (cm) 241 101.1 (4.9) 252 100.8 (5.5) 0.34 (−0.46 to 1.14) .40
Subscapular skinfold thickness (mm) 204 7.8 (3.2) 215 8.1 (3.4) −0.30 (−0.92 to 0.31) .33
Triceps skinfold thickness (mm) 216 12.3 (4.1) 228 12.1 (3.7) 0.23 (−0.49 to 0.97) .52
Biceps skinfold thickness (mm) 212 8.3 (3.7) 226 8.3 (3.3) 0.01 (−0.65 to 0.67) .97
Super iliac skinfold thickness (mm) 194 6.8 (3.4) 202 7.2 (4.14) −0.40 (−1.15 to 0.34) .28
Abdomen skinfold thickness (mm) 196 9.4 (4.8) 211 9.6 (4.2) −0.20 (−1.06 to 0.66) .64
Sum of skinfolds (mm) 185 39.8 (33.4 to
48.8)
196 42 (34.5 to
51.0)
−2.00 (−4.64 to 0.62) .13
Waist Circumference (cm) 238 53.0 (4.5) 241 53.2 (4.2) −0.16 (−0.92 to 0.60) .67
Mid upper arm circumference (cm) 231 17.8 (1.6) 239 17.7 (1.9) 0.04 (−0.26 to 0.36) .76
BMI for age z-score b, c 236 0.88 (1.0) 249 0.88 (1.0) 0.004 (−0.18 to 0.19) .96
Percentage with obesity (IOTF definition) c 230 20 (8.8) 243 20 (8.2) 1.06 (0.55 to 2.04) .86
Percentage overweight/obesity (IOTF
definition) c
230 73 (31.7) 243 93 (38.3) 0.73 (0.50 to 1.08) .11
Body fat percentage calculated from BIA 186 22.3 (7.1) 196 22.4 (6.1) −0.30 (−1.62 to 1.01) .65
Pulse rate (bpm) 199 91 (20.0) 204 96 (17.4) −4.8 (−8.41 to −1.07) .01
Systolic blood pressure percentile 197 80 (63 to 91) 207 78 (63 to 90) 2.79 (−1.81 to 7.39) .23
Diastolic blood pressure percentile 196 79 (57 to 91) 205 82 (64 to 88) −2.98 (−7.76 to 1.08) .22
Abbreviations: BIA, bioelectrical impedance analysis; BMI, body mass index; BPM, beats per minute; CI, confidence interval; IOTF, international obesity
task force; IQR, interquartile range; mm, millimetres; cm, centimetres; kg, kilograms, SD, standard deviation.
aTreatment effect adjusted for minimisation variables of randomisation maternal BMI, parity & ethnicity, child age at 3 year follow up and sex.
bZ-scores calculated using WHO Anthro (de Onis, 2006).
cNot adjusted for child age or sex.
F IGURE 2 Resting pulse rate at 3-years of age, by randomisation arm
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trend towards lower diastolic blood pressure percentiles for children
born to mothers from the intervention arm (−2.98; −7.76, 1.08) did
not reach statistical significance (Table 3). Sensitivity analyses using
multiple imputation for the whole trial population demonstrated a
consistent reduction of resting pulse rate in the intervention arm
(−4.8 bpm [−8.37 to −1.23]) and similar results for other offspring
outcomes (Supplementary, Table S4).
3.4 | Effect of the intervention on maternal diet
and body composition three years postpartum
Compared to women who received standard antenatal care, women
in the intervention arm who provided complete dietary data
reported lower glycaemic load, maternal energy and SFA intake, and
higher protein intake three years after delivery (Supplementary,
Table S5). Figure 3 illustrates these data with previous measure-
ments throughout the index pregnancy and at six months postpar-
tum, showing a sustained effect of the intervention from pregnancy
to three years post-delivery. There were no differences in self-
reported physical activity (Supplementary, Table S5) or in measures
in body composition between the two trial arms (Supplementary,
Table S6).
4 | DISCUSSION
To our knowledge this investigation of 514 pre-school children born to
mothers with obesity randomised to a lifestyle intervention in preg-
nancy is the most comprehensive reported to date. In a previous study
in UPBEAT infants at six months of age (n = 698), we reported a reduc-
tion in subscapular skinfold thickness, a measure which, in adults, is
associated with risk of metabolic disease.30 At three years of age this
effect was not sustained, despite trends towards lower adiposity, a
lower incidence of overweight/obesity and diastolic blood pressure in
the intervention group. The reduction in resting pulse rate in three-
year-old children of mothers randomised to a lifestyle intervention, is
an entirely novel observation. Notably, we found that the improvement
in maternal diet during pregnancy in response to the UPBEAT interven-
tion is still evident three years after delivery.
The reduction in the resting pulse rate of the three-year-old chil-
dren could imply reduced cardiovascular risk. In adult populations,
increased resting pulse rate is associated with hypertension and cardio-
vascular dysfunction.31 Of the few reports in children, a higher resting
pulse rate has, as might be anticipated, been related to higher blood
pressure.32 Resting pulse rate in children has also been reported to be
inversely related to physical activity,33 but this is an unlikely explanation
for the difference in pulse rates observed between intervention arms in
F IGURE 3 Maternal dietary intake across pregnancy and to 3-years postpartum, by randomisation arm
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this study, as there was no association with parent-reported child activ-
ity and sedentary time and resting pulse rate. An association between
maternal obesity and offspring cardiometabolic dysfunction is widely
reported in experimental animals.13-16,34 Rodent maternal obesity has
been related to a sustained increase in offspring central sympathetic
activity at the level of the hypothalamic neuronal pathways involved in
peripheral autonomic regulation. In turn, this central pathway has been
implicated in the sustained increase in blood pressure and altered heart
rate variability observed.16 Mechanistically this may occur through per-
manently changed hypothalamic function through epigenetic pro-
cesses.35,36 Our data could support a similar pathway to sympathetic
activation in the children of women with obesity, and prompts more
detailed investigation of sympathetic pathways and the epigenome in
UPBEAT children at an older age. Assessment of the heart rate variabil-
ity using ECG recordings, for example, would provide a read out of
efferent parasympathetic and sympathetic autonomic activity37 and the
peripheral blood epigenome may provide insight into sustained epige-
netic signals originating in utero. A recently published study of
184 women provides added support for in utero origins of altered auto-
nomic nervous system activity.38 Using the method of magnetoenceph-
alography, the authors reported that maternal overweight and obesity
was associated with lower fetal heart rate variability and a higher heart
rate, in comparison to normal weight mothers. Furthermore, in a prelim-
inary analysis of a study focusing on MRI assessment of newborn car-
diovascular function, we have recently shown a significantly higher
heart rate associated with abnormal cardiac structure and function in
neonates born to mothers with obesity compared to those born to lean
mothers (A. Groves, personal communication).
We could find no obvious explanation for the bimodal distribution
of heart rate observed in the children as it was not influenced by
maternal dietary intake or resting pulse rate, child's diet, weekly activ-
ity and sedentary time, time of day, seasonality or centre of measure-
ment (heart rate monitoring device). To our knowledge this clear
bimodal distribution has not been previously reported and the origin
remains unknown.
The observation that the effect of the intervention on maternal
diet was maintained to three years, having previously been demon-
strated at six months24 is important and has potential implications for
longer term maternal and family health. It supports the theory that
pregnancy is a “teachable” moment for initiating longer-term improve-
ments in dietary intake.39 In a planned follow up of the older children,
we shall explore long term effects of the intervention on the mothers'
behaviours and her health outcomes including obesity, Type 2 diabe-
tes, hypertension and cardiovascular disease. Healthier behaviours in
mothers may also impact upon the health of her offspring as they age,
and of other family members, although we have previously reported
no differences between dietary patterns in the 3 year old children
from mothers in the standard care and intervention arms 40. As the
children grow older, we shall nonetheless assess relationships
between in utero and contemporary family exposures with child
health outcomes. As persistently healthier maternal behaviours may
also impact on the next pregnancy, maternal and infant health in sub-
sequent pregnancies will also be of interest.
Although there are many reports of the consequences of maternal
obesity on offspring health from animal15 and cohort studies7 very
few have addressed the influence of an antenatal intervention beyond
infancy.21 The only study of an antenatal diet and physical activity
intervention in women with obesity, which was effective at reducing
GWG, reported no effect on offspring body composition at 2.8 years
of age (n = 254).41 In conjunction with our six month24 outcome data,
this report and the present study suggest that these effects may
diminish in the children over time. Alternatively, the lack of any signifi-
cant reduction in overweight or obesity may reflect a different timing
of the adiposity rebound, typically occurring in this age group. How-
ever, as the two arms of this RCT were well matched the distribution
of age at adiposity rebound would be expected to similar between
groups. Alternatively, the higher proportion of LGA infants in the
intervention arm, not observed in the original study population,22 may
have obscured a difference, as infants born LGA may retain a higher
BMI throughout childhood and adolescence.42
Whilst UPBEAT and other similar RCTs have found positive effects
of lifestyle interventions on maternal lifestyle behaviours and GWG, the
magnitude of change is often modest. For example, in a recent individ-
ual participant meta-analysis of 36 antenatal lifestyle RCTs
(n = 12 526) in pregnant women of heterogenous BMI, the reduction
in total GWG was a modest −0.7 kg (−0.92, −0.48). A lower caesarean
section rate was the clinical outcome to show improvement.20 The
robust association between maternal obesity and childhood obesity
across many observational studies6,7 could result from shared
obesogenic genes, or shared family environment, or a persistent influ-
ence of in utero exposures on the developing fetus or a combination of
all of these. Although we have found, as reported here, an effect of a
lifestyle intervention which improved maternal metabolic health in
women with obesity (and presumably fetal exposures) on the cardiovas-
cular system of the children, interventions which substantially affect
the maternal phenotype and metabolic health are required before firm
conclusions can be made as to the contributions of pre and postnatal
determinants of the child's health. Future strategies may include, for
example, targeted behavioural interventions in women with obesity
stratified as being at higher risk of adverse outcomes, especially GDM,
which may have a lasting independent effect on offspring health.43 The
repeatedly demonstrated modest effect of lifestyle interventions on
pregnancy outcomes, has contributed to a new focus on optimising
BMI before pregnancy. Pre-conception interventions, not limited to the
narrow gestational window of nine months, are now seen by many as a
as a potentially more effective strategy for improving pregnancy and
longer-term outcomes for mother and child.44 Ultimately, effective
interventions which together improve health behaviours in the precon-
ception period and achieve substantive improvements in pregnancy
outcomes, will inevitably have greater reach and benefit.
4.1 | Strengths and limitations
Strengths of the study include the prospective collection of in-depth
data of pregnancy demographic, health, metabolic and lifestyle
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variables and individual determinants of childhood body composition
and health outcomes, allowing for adjustment of potential con-
founders. The principal limitation is the follow-up of 33% of those eli-
gible from the original RCT,22 and some minor differences in baseline
characteristics between the two trial arms, may have resulted in selec-
tion bias. The main outcomes were however consistent when compar-
ing complete case analyses with those from analyses using
multivariable regression to impute data from those lost to follow-up.
The consistency between the two methods suggests that selection
bias may not have importantly influenced our findings.45
The lack of a significant reduction in GWG and pregnancy meta-
bolic function between women in the trial arms who attended the fol-
low up study, contrasts with the main trial and may have influenced
the childhood outcomes, although the intervention mothers in this
study sample demonstrated a similar reduction in measures of adipos-
ity as reported in the main trial. The higher resting pulse rate in the
standard care arm vs the intervention arm was an additional outcome
and has not been explored previously. This may be due to chance
given the number of multiple tests performed. However, as described
above, observations of a higher fetal and neonatal heart rate in off-
spring of mothers with obesity compared to those of women with a
normal BMI add validity to this observation. Replication, ideally in
another large RCT with minimal loss to follow-up is, nonetheless
required for validation. Additionally, pulse rate should be assessed in
duplicate or triplicate in future studies.
Skinfold thicknesses and BIA are indirect methods for assessing
body fat mass and distribution and future studies should consider
dual-energy x-ray absorptiometry (DXA) which is practically more fea-
sible in older children. A further limitation is the use of self-reported
FFQ for the dietary intake in the mothers, although, during the pilot
for UPBEAT the food frequency questionnaire performed favourably
against a more rigorous method for dietary assessment.46
In conclusion, this study provides some evidence to suggest that
improving health behaviours in women with obesity may have a posi-
tive effect on cardiovascular health of the offspring but is not associ-
ated with a reduction in childhood adiposity at the age of three years.
The intervention in pregnancy, in common with many other studies,
had only modest effects on maternal diet, weight gain, and adiposity.
It remains important therefore to develop better interventions in preg-
nant women with obesity before or during pregnancy which substan-
tially improve maternal health, and to determine if these are
associated with greater health benefits for the child. Importantly, we
found that the improved dietary behaviours arising from the UPBEAT
intervention were maintained three years after delivery. Further
follow-up of the UPBEAT participants will be valuable in ascertaining
the longer-term effects of the UPBEAT intervention and the mother's
diet on her and her offspring's health, including detailed assessment of
cardiovascular function and adiposity.
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